Literature DB >> 16935944

Advances in macrophage and dendritic cell biology in HIV-1 infection stress key understudied areas in infection, pathogenesis, and analysis of viral reservoirs.

Luis J Montaner1, Suzanne M Crowe, Stefano Aquaro, Carlo-Federico Perno, Mario Stevenson, Ronald G Collman.   

Abstract

The continued quest to intervene in HIV-1 infection by halting transmission, suppressing replication, or eradicating disease in infected subjects stresses the significance of dendritic cell and macrophage biology as early and persistent players in the relationship between infection and disease. As highlighted by new data and presentations at the Sixth International Workshop on HIV and Cells of Macrophage/Dendritic Lineage and Other Reservoirs, a greater emphasis is currently underway in studying the potential of targeting these cell types by intervention early in infection, better defining viral phenotypes and entry mechanisms with a more precise nomenclature system, identifying new, intrinsic cellular factors that may restrict infection within these cell types, and pursuing novel roles for macrophage activation and trafficking. Other key areas include examination of these cells as sources of viral persistence in patients, their roles in coinfection, and their metabolic function in HIV pathogenesis and drug toxicity. This issue of JLB contains reviews and original research reports from the workshop, which highlight new findings, current research questions, and key areas in need of future investigation as a result of their significance to HIV prevention and pathogenesis.

Entities:  

Mesh:

Year:  2006        PMID: 16935944     DOI: 10.1189/jlb.0806488

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  30 in total

1.  Effect of alcohol on drug efflux protein and drug metabolic enzymes in U937 macrophages.

Authors:  Mengyao Jin; Priyanka Arya; Kalpeshkumar Patel; Bhupendra Singh; Peter S Silverstein; Hari K Bhat; Anil Kumar; Santosh Kumar
Journal:  Alcohol Clin Exp Res       Date:  2010-10-06       Impact factor: 3.455

2.  Macrophage internal HIV-1 is protected from neutralizing antibodies.

Authors:  Herwig Koppensteiner; Carina Banning; Carola Schneider; Heinrich Hohenberg; Michael Schindler
Journal:  J Virol       Date:  2011-12-28       Impact factor: 5.103

Review 3.  Antiretroviral therapy in macrophages: implication for HIV eradication.

Authors:  Christina Gavegnano; Raymond F Schinazi
Journal:  Antivir Chem Chemother       Date:  2009-10-19

4.  Abundant non-canonical dUTP found in primary human macrophages drives its frequent incorporation by HIV-1 reverse transcriptase.

Authors:  Edward M Kennedy; Waaqo Daddacha; Rebecca Slater; Christina Gavegnano; Emilie Fromentin; Raymond F Schinazi; Baek Kim
Journal:  J Biol Chem       Date:  2011-03-31       Impact factor: 5.157

5.  A LC-MS/MS method for concurrent determination of nicotine metabolites and role of CYP2A6 in nicotine metabolism in U937 macrophages: implications in oxidative stress in HIV + smokers.

Authors:  Mengyao Jin; Ravinder Earla; Ankit Shah; Rajya L Earla; Raeesa Gupte; Ashim K Mitra; Anil Kumar; Santosh Kumar
Journal:  J Neuroimmune Pharmacol       Date:  2011-06-08       Impact factor: 4.147

6.  Short communication: The dead cell: a potent escort for HIV type 1 transinfection.

Authors:  Robert Sealy; Bart G Jones; Sherri L Surman; Julia L Hurwitz
Journal:  AIDS Res Hum Retroviruses       Date:  2009-11       Impact factor: 2.205

7.  Expression of MDM2 in Macrophages Promotes the Early Postentry Steps of HIV-1 Infection through Inhibition of p53.

Authors:  Yann Breton; Vincent Desrosiers; Michel Ouellet; Alexandre Deshiere; Cynthia Torresilla; Éric A Cohen; Michel J Tremblay
Journal:  J Virol       Date:  2019-03-21       Impact factor: 5.103

8.  CA Mutation N57A Has Distinct Strain-Specific HIV-1 Capsid Uncoating and Infectivity Phenotypes.

Authors:  Douglas K Fischer; Akatsuki Saito; Christopher Kline; Romy Cohen; Simon C Watkins; Masahiro Yamashita; Zandrea Ambrose
Journal:  J Virol       Date:  2019-04-17       Impact factor: 5.103

9.  Clonal sequences recovered from plasma from patients with residual HIV-1 viremia and on intensified antiretroviral therapy are identical to replicating viral RNAs recovered from circulating resting CD4+ T cells.

Authors:  Jeffrey A Anderson; Nancie M Archin; William Ince; Daniel Parker; Ann Wiegand; John M Coffin; Joann Kuruc; Joseph Eron; Ronald Swanstrom; David M Margolis
Journal:  J Virol       Date:  2011-03-02       Impact factor: 5.103

10.  Vpu serine 52 dependent counteraction of tetherin is required for HIV-1 replication in macrophages, but not in ex vivo human lymphoid tissue.

Authors:  Michael Schindler; Devi Rajan; Carina Banning; Peter Wimmer; Herwig Koppensteiner; Alicja Iwanski; Anke Specht; Daniel Sauter; Thomas Dobner; Frank Kirchhoff
Journal:  Retrovirology       Date:  2010-01-15       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.